Biocon And Biomm Team Up In Brazil On Ozempic Rival – With Potential Near-Term Launch
Partnership On Semaglutide Comes Shortly After Landmark UK Liraglutide Nod
India’s Biocon Limited has struck an exclusive deal for a generic version of semaglutide in Brazil with local player Biomm. And a recent court ruling means that launch could come sooner rather than later for the Ozempic rival.
